Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof

US10213384B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10213384-B2
Application numberUS-201815883134-A
CountryUS
Kind codeB2
Filing dateJan 30, 2018
Priority dateApr 28, 2009
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention teaches a foamable pharmaceutical and cosmetic compositions comprising an aprotic polar solvent; foam compositions and uses thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-aqueous composition formulated for skin delivery of an active agent comprising: a minocycline in a therapeutically effective amount of about 1% to about 5% by weight of the composition; a short chain alcohol comprising ethanol present in an amount of at least 55% by weight of the composition; about 12% to about 50% by weight of the composition of a protic polar solvent comprising propylene glycol; a polymeric agent comprising a cellulose ether, wherein the cellulose ether is a hydroxypropyl cellulose present in an amount ranging from about 0.5% to about 1% by weight of the composition; a modulating agent comprising an antioxidizing agent present in an amount ranging from about 0.1% to about 10% by weight of the composition; a metal; and an essential oil, wherein the composition is surfactant free, non-aqueous, and free or essentially free of fatty alcohol. 2. The non-aqueous composition according to claim 1 , wherein the minocycline is dissolved in the composition. 3. The non-aqueous composition according to claim 2 , wherein the minocycline is a minocycline hydrochloride. 4. The non-aqueous composition according to claim 1 , wherein the protic polar solvent is about 12% to about 30% by weight of the composition.

Assignees

Inventors

Classifications

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Drugs for dermatological disorders · CPC title

  • containing sulfur (A61K8/44 takes precedence) · CPC title

  • Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters · CPC title

  • Preparations for care of the skin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10213384B2 cover?
The present invention teaches a foamable pharmaceutical and cosmetic compositions comprising an aprotic polar solvent; foam compositions and uses thereof.
Who is the assignee on this patent?
Foamix Pharmaceuticals Ltd
What technology area does this patent fall under?
Primary CPC classification A61K9/122. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).